Fundz

PIC Therapeutics Raises $5 Million to Advance Development of Small Molecules That Selectively Modulate eIF4E

PRIVATEApr 15, 2020

Amount Raised

$5 Million

Round Type

Funding Round

NatickBiotechnology

Description

PIC Therapeutics (“PIC”), a biotechnology company focused on transforming the treatment of cancer though the selective modulation of oncogene translation, closed a $5M Series Seed round of preferred equity funding.

Quick answer

Pic Therapeutics raised $5 Million in a Funding Round round, dated April 15, 2020. Pic Therapeutics is based in Natick, Massachusetts, United States.

How much did Pic Therapeutics raise?
Pic Therapeutics raised $5 Million in a Funding Round round on April 15, 2020.
What does Pic Therapeutics do?
PIC Therapeutics is a biotechnology company focused on fundamentally changing how we treat cancer by developing a new generation of therapeutics based on the modulation of RNA translation.
Where is Pic Therapeutics based and how big is it?
Pic Therapeutics is based in Natick, Massachusetts, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Pic Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Atea Pharmaceuticals, Inc. raised $107M on May 29, 2020.
  • Luna Genetics raised $1.2M (Seed) on May 29, 2020.
  • Hilltop Biosciences raised $150K (Seed) on May 29, 2020.
  • INVO Fertility, Inc. raised $2.1M (Seed) on May 28, 2020.
  • Artio Medical, Inc. raised an undisclosed amount on May 28, 2020.
  • Personalized Stem Cells, Inc. raised $1.6M (Seed) on May 28, 2020.

Who to call at Pic Therapeutics, and when

A new round usually means Pic Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Pic Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Pic Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Pic Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Pic Therapeutics

Location

22 Strathmore Road

Natick, Massachusetts, United States

About

PIC Therapeutics is a biotechnology company focused on fundamentally changing how we treat cancer by developing a new generation of therapeutics based on the modulation of RNA translation. PIC Therapeutics was founded on the seminal work of Dr. Gerhard Wagner, a professor at Harvard Medical School world-renowned for his scientific expertise in protein structure and his research on interactions of eukaryotic translation initiation factors (eIFs). PIC Therapeutics, led by President and CEO Dr. Kathy Bowdish, was launched to translate these discoveries into small molecule precision therapeutics to benefit cancer patients. Our precision-based therapeutics target the “master switch” of cancer signaling pathways, selectively blocking oncogene protein production by modulating the Pre-Initiation Complex (PIC) that drives their mRNA translation. Our selective approach has the potential to simultaneously modulate multiple oncogenic drivers leading to a powerful new generation of cancer-treating therapeutics.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Pic Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Pic Therapeutics's next move

See what Strategic adds

Pic Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.